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Abstract
Objective: To qualitatively explore associations between emotional responses to experience of cancer
‘alarm’ symptoms and help-seeking in a community sample of adults.
Method: Interviewees (n = 62) were recruited from a community sample (n = 2042) of adults aged
≥50 years, who had completed a health survey that included a list of cancer alarm symptoms.
Participants who had reported an alarm symptom both at baseline and 3-month follow-up (n = 271),
and who had consented to contact (n = 215), constituted the pool for invitations to interview.
Results: Over a third of participants (37%) described an emotional response to their symptom
experience. In all these cases, there was evidence of awareness of the risk of cancer. Emotional
responses were usually either classiﬁed as mild (‘worry’) or severe (‘fear’). Worry was often described
in the context of a desire to seek medical help, either to rule out cancer or to minimise patient delay. In
contrast, the ‘fear’ group described associations with death, the perceived incurability of cancer, and
the consequence of a cancer diagnosis. Where the emotional reaction was fear, medical contact was
seen as something to be avoided either because it had no value or because it was preferable not to
be told a diagnosis.
Conclusion: In this community sample, worry about the possibility of cancer was associated with
help-seeking, either for reassurance or as part of a ‘sensible’ strategy to deal with the risk. In contrast,
fear was associated with avoiding help-seeking or even thinking about cancer, which could lead to
prolonged help-seeking intervals.
© 2015 The Authors. Psycho-Oncology published by John Wiley & Sons Ltd.
Introduction
Emotional responses to symptoms are likely to be an im-
portant inﬂuence on behavioural responses [1]. The symp-
tom appraisal process (‘time from detection of a bodily
change to perceiving a reason to discuss symptoms with
a health care practitioner’) [2] is considered a key step in
relation to achieving earlier presentation, earlier cancer
diagnoses, and thereby better cancer outcomes [3]. It is
possible that a better understanding of the role of emo-
tional responses could help explain some of the variation
in help-seeking.
There have been many studies in which patients/people
diagnosed with cancer are asked to reﬂect back on how
they responded to their ﬁrst symptom, often focusing on
delay in help-seeking. In a qualitative synthesis, fear was
identiﬁed as a key reason for delay, second only to not
recognising the signiﬁcance of the symptom [4]. Predom-
inantly the fear was of cancer itself or its treatment or side
effects, but also included aspects of the help-seeking pro-
cess (e.g. being seen as neurotic). Other studies have also
identiﬁed fear of investigations, and fear of diagnosis or
treatment as risk factors for patient delay in upper gastro-
intestinal, colorectal, urological, gynaecological, and lung
cancers [5]. However, fear is not always found to be a
deterrent. In one study, patients who recalled being more
anxious when they detected a breast symptom tended to
have sought help more promptly than those who had less
of an emotional response [6]. Another study, focusing
speciﬁcally on fear intensity concluded that higher levels
of fear facilitated rather than hindered help-seeking [7].
Finally, a recent systematic review of studies with patients
also highlighted the mixed impact of emotions on time to
presentation, concluding that more emotion-focused re-
search was needed in order to unravel its complexity [8].
A different approach to investigating the role of fear is
to examine emotional reactions to symptoms in general
population samples, and link these to help-seeking. This
avoids the retrospective bias inevitable in clinical recall
studies, and also includes people who have symptoms
but do not ultimately receive a cancer diagnosis. In a
population-based survey asking about help-seeking for
hypothetical symptoms (‘If you had a symptom you
thought might be serious, what might put you off help-
seeking’), worry about what the doctor might ﬁnd was
the most commonly endorsed emotional barrier, and per-
ceiving more barriers to help-seeking was associated with
longer anticipated delay [9]. However, use of reactions to
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‘hypothetical’ symptoms and ‘anticipated’ help-seeking
has its own problems in that people may not be good at
predicting how they would really act if the situation arose.
One alternative is to study people’s emotional responses
to symptoms they are actually experiencing and link them
to help-seeking. Recent research with a community sam-
ple suggested that people who were afraid of the conse-
quences of seeking help (e.g. investigations or treatment)
tended to avoid contacting their doctor for a recently
experienced cancer ‘alarm’ symptom, but paradoxically,
awareness of a possible link with cancer (which is usually
linked with some degree of fear) tended to promote help-
seeking [10]. However emotional responses to symptoms
were not explored in any depth.
The aim of the present study was therefore to explore
emotional reactions in a qualitative study of a sample of
adults reporting persistent cancer alarm symptoms, and
examine associations with past or planned help-seeking.
Methods
Participant selection and recruitment
Interviewees were recruited from participants (n=2042)
from a large mailed ‘health survey’ conducted through
four General Practices in England across London, the
South East, and the North West of England, which had
been mailed to 4913 individuals aged ≥ 50 years in
October 2013. Participants reporting at least one cancer
‘alarm’ symptom (n=936) were sent a follow-up survey
after 3 months to capture persistent symptoms. Those
who were still experiencing the symptom at the 3-month
follow-up (n=271), and who consented to contact (n=215),
constituted the pool from which we invited people to inter-
view. We invited the ﬁrst 144 participants meeting our
criteria, and obtained a response rate of 60% (86/144). In-
terviews ceased once data saturation was achieved (n=62)
(Figure 1). Interviews were conducted as soon as possible
after participants returned the follow-up health survey, and
all were conducted within 4 weeks of receipt of the survey.
The study materials and protocol were approved by NHS
London Bridge Research Ethics Committee (Reference:
11/LO/1970).
Symptoms from the ‘health’ survey
Ten cancer ‘alarm’ symptoms were taken from the Cancer
Awareness Measure (CAM) [11] and represented symp-
toms relevant to a range of cancers. We added abdominal
bloating and breast changes from the ovarian and breast
cancer speciﬁc versions of the CAM [12,13] and blood
in urine and rectal bleeding which were at the time
being highlighted in the media Be Clear on Cancer
campaigns designed to raise awareness of bladder and
bowel cancer [14].
Interview
Interviews were carried out during a period where people’s
symptom experiences were ongoing, and were intended
to capture current appraisal, attribution, and decision-
making. Interviews were conducted at participants’
homes (n=8), at UCL ofﬁces (n=15), or over the tele-
phone (n=39), as the participant preferred, by CR, KW,
and KeW. Participants were asked to talk about various
aspects of their symptom(s) including when they ﬁrst
noticed it, their thoughts and feelings about it over time,
and any action(s) they had taken. The word ‘cancer’
was not used by the interviewer unless the participant
mentioned it, to avoid biasing sense-making and attribu-
tion accounts. After the initial narrative account, a semi-
structured topic guide was used to ensure that emotional
responses were explored in sufﬁcient detail. We used
prompts to ask about emotional responses if they did
not arise spontaneously, such as mentioning the experi-
ence of other interviewees (e.g. ‘some people have men-
tioned that they avoid seeing the GP because they are
worried about what the GP might tell them, did this ever
apply to you’). Interviews lasted on average 42 min
(range 22–66 min).
Analysis
Interviews were digitally recorded and transcribed verba-
tim by freelance transcribers. KW and KeW checked
all transcriptions against portions of each recording and
found them to be accurate. SC and KW read and re-read
the transcripts, and agreed a coding frame. Transcripts
were coded, managed, and analysed using NVivo 9.0
software (QSR International Pty Ltd. 2010). Framework
analysis [15] was used to create a matrix to organise the
data. Data were summarised in sub-themes under the
broader themes of ‘Worry’ and ‘Fear’ (Box 1). Emerging
sub-themes were discussed in frequent meetings, and
agreed by all the co-authors. An iterative process of
revisiting the original transcripts was used to ensure that
the ﬁnal interpretation was representative of participants’
accounts. Demographic and basic frequency information
was analysed using SPSS Version 21.0.
Results
The average age of participants was 64.5 years (SD=9.3).
Both sexes were represented (47% women, 53% men).
Most (92%) were White British (n=57), and 45% (n=28)
had university-level education. This was comparable to
the demographics of the wider survey sample (n=2042).
The most common symptom reported in the interview
sample was persistent cough/hoarseness (34%), and there
were no reports of breast changes (Table 1). People were
most likely to have sought help for persistent unexplained
pain (73%).
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Of sixty-two people interviewed, 23 (37%) described at
least one emotional response to their symptom. In all these
cases, participants were aware of a possible link with
cancer. Emotional responses were invariably in the domain
of worry/anxiety/fear and tended to be clearly identiﬁable
as mild and more cognitive (which we termed ‘worry’) or se-
vere and highly affectively charged (which we termed ‘fear’).
Figure 1. Flowchart of recruitment
Box 1 Emotional responses to cancer ‘alarm’ symptoms
Worry Fear
• Possibility of cancer • Association with death
• Symptom seriousness • Incurability of cancer
• Consequences of late diagnosis • Negative views of treatment
• Preference for remaining
ignorant of a diagnosis (‘Ignorance
is bliss’)
Emotional response to ‘alarm’ symptoms
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Worry
Worry about cancer/symptom seriousness
The most commonly reported emotional response in rela-
tion to cancer ‘alarm’ symptoms was mild worry, with
people questioning whether their symptom might be seri-
ous or indicative of cancer; although mostly they did not
expect a cancer diagnosis. Help-seeking was often de-
scribed as seeking reassurance ‘that it isn’t something
serious’ (P42, F, persistent change in bowel habits):
‘I just wanted reassurance that it wasn’t a cancerous
thing. When she said that it wasn’t, then that was okay’
(P43, F, change in the appearance of a mole).
‘Well, I think most intelligent people going to the doctor
have some sort of idea of what they think is wrong with
them when they go, and often they are hoping for conﬁr-
mation and to rule out that it’s not something else more
worrying’ (P21, F, persistent change in bowel habits,
abdominal bloating, change in the appearance of a
mole).
Worry about later diagnosis
Another issue was the implication of delaying help-
seeking if the symptoms were because of cancer. Again
participants in this group reported only relatively low
key emotional responses: ‘if you catch things early, quite
often you can get cured, whereas if you delay and delay
and delay, you’ve past a point of no return’ (P10, M,
persistent cough). This type of response to ‘alarm’ symp-
toms appeared to be a rational and considered approach to
getting it ‘caught as early as I can’ (P11, M, persistent
change in bowel habits).
Fear
A small number of participants described a much more
affectively charged emotional response to their symptoms,
which we termed ‘fear’. This included fear of death, the
incurability of cancer, or fear about the consequences of
a cancer diagnosis such as treatment or dependence on
others. People reporting fear often appeared uncomfort-
able both talking about cancer and describing their
feelings.
Association with death
Participants highlighted the urge to delay the awareness of
mortality and death. When one participant was asked why
he was scared about his symptom potentially indicating
cancer, he explained:
‘Because my feelings of immortality might disappear quite
suddenly. I mean, it’s the big “C”, that’s what worries
people. Because it’s cancer and cancer kills’ (P22, M,
persistent cough).
‘I was trying not to think of cancer, although it’s, I sup-
pose, you know, as human beings we often think one thing.
But I was trying not to, I was trying to be positive or to…
as I said, I had also this experience of my friend who
just died of that, so it was a bit, if you like, in the back
of my mind, but I was trying not to let it inﬂuence me
too much’ (P19, F, unexplained weight loss, persistent
cough).
Fear of the incurable
People also described feeling sceptical about what could
be done if they were diagnosed with cancer because
there’s ‘no guarantee of a cure’ (P16, F, persistent change
in bladder and bowel habits, abdominal bloating).
‘And I suppose the other thing about cancer, any cancer,
is cure rate is improving, but it’s still… I’m not sure. I
mean, different cancers have different treatment success
rates, but, you know, you’ve still got a, sort of, one in
two, one in three, one in four chance, depending on what
the cancer is, of not being treated successfully’ (P22, M,
persistent cough).
‘I’m kind of expecting that there won’t be much that anybody
can do about it’ (P56, M, persistent change bladder habits).
He went on to illustrate all aspects of cancer fear in his re-
sponse: ‘I mean, the cancer with a capital C, the bête-noir
element, the fear of the unknown and the incurable, that’s
where the fear comes from’ (P56, M, persistent change in
bladder habits).
Table 1. Type of symptoms and help-seeking reported in the past
3 months in the interview sample
Symptom
Interviewees
reporting
symptom n (%)*
Interviewees who
had contacted the GP
about the symptom
n (%)**
Persistent cough/hoarseness 17 (27.4) 6 (35.3)
Change in bladder habits 15 (24.2) 7 (46.7)
Change in bowel habits 12 (19.4) 4 (33.3)
Abdominal bloating 16 (25.8) 6 (37.5)
Unexplained pain 12 (19.4) 7 (72.7)
Change in mole 7 (11) 2 (28.6)
Rectal bleeding 4 (6.5) 2 (50)
Unexplained lump 4 (6.5) 1 (25)
Difﬁculty swallowing 6 (9.7) 1 (20)
A sore that does not heal 5 (8.1) 1 (20)
Unexplained weight loss 3 (4.8) 1 (50)
Blood in urine 2 (3.2) 1 (50)
Unexplained bleeding 2 (3.2) 0 (0)
*Denominator is number of people in the interview sample (n = 62).
**Percentages may not sum because of missing data.
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Fear of treatment
Some participants speciﬁcally described fear of the treat-
ment they would receive if they did receive a cancer
diagnosis.
‘If it was something like cancer, something major, and
then the treatment, obviously, can be awful’ (P40, F, per-
sistent change in bladder habits, persistent difﬁculty
swallowing, persistent cough, rectal bleeding).
This also extended to how the treatment would im-
pact on their lifestyle, with many expressing concern
over imposing themselves on others, and becoming a
burden.
‘I have to be honest, that is a fear in me. I don’t want to be
dependent. It’s my independence thing. I think if I got old
and, sort of, incapacitated, couldn’t look after myself, I
don’t think I’d like that at all. I don’t think so. I don’t know
what I’d do, to be honest. With that, I do put my head in
the sand and try not to think about it’ (P57, M, persistent
cough).
Ignorance is bliss
Many participants described not wanting to seek medical
advice because ‘ignorance is bliss’ (P33, F, change in
the appearance of a mole, persistent change in bowel and
bladder habits, persistent unexplained pain). In general,
this response was related to concern about getting bad
news: ‘being frightened of what it may be’ (P54, F, persis-
tent unexplained pain). People often used alternative ter-
minology to describe the possibility of cancer (the big
‘C’, ‘it’, and ‘the big demon’), ‘because it’s a horrible
word’ (P35, F, 55, persistent change in bowel habits,
abdominal bloating).
‘I’m not worried about the investigation. I might be wor-
ried about the outcome of the investigation’ (P41, M,
persistent change in bladder habits, persistent cough).
‘I’d rather not know. Well, you might have something
serious. I’d rather not know.’ (P10, M, persistent
cough).
‘I suppose you are just frightened of what it might be.
That’s all, really, basically. I don’t know, it’s just the
way I feel, I suppose. It is a bit frightening when you are
not sure what it might be and you think it could something
not very nice. I suppose that’s just the way that I am, the
way I think, I suppose’ (P54, F, unexplained persistent
pain).
One participant rationalised this further and weighed up
the idea that living with the possibility of a cancer diagno-
sis was not as bad as knowing for certain that one has
cancer:
‘I’ve rationalised it to myself by saying, “Well, if I’m
going to live with it then I’d rather not be living in fear
of when it’s going to strike me down. I’d rather just be
living with the vague suspicion that perhaps it might be
but it’s more likely to be an enlarged prostate.” So I’m
hiding fright, to a certain extent’ (P56, M, persistent
change in bladder habits).
Discussion
In this community sample of people experiencing ongo-
ing cancer ‘alarm’ symptoms, we observed two distinct
groups of emotional response. One we called ‘worry’,
and this was associated with concern about the possibility
of cancer, and the potential for late diagnosis. In this
group, the emotional response seemed to be mild, and
in general these participants appeared to feel that they
were capable of coping with a cancer diagnosis, although
partly this could be because they typically perceived it as
a relatively low probability. Those in the ‘fear’ category
were clearly frightened about the implications of receiv-
ing a cancer diagnosis, associating it with incurability
and death, or fearing treatment and the impact of a cancer
diagnosis on daily life. By and large, they tended to avoid
thinking about cancer and avoided contact with doctors
that could result in such a diagnosis.
Lower-level emotional responses such as worry have
previously been reported by oral cancer patients, who
rarely recalled distress in relation to their initial symp-
toms, but when they did describe it as general worry or
concern [16]. The fearful responses matched previous
ﬁndings with patients/people diagnosed with cancer where
fear was described as a deterrent to help-seeking because
of feeling unable to cope with a cancer diagnosis, or
dreading treatment and the impact on daily life [4,5].
Unlike some suggestions from previous work [7], we
found little evidence that high levels of cancer fear trig-
gered help-seeking. Rather, high levels of emotional
response were associated with avoidance, both in terms
of the cancer discourse in general, and in terms of help-
seeking. It was the lower levels of emotional response
(worry or concern) that were mentioned as promoting
help-seeking, either to provide reassurance or to do the
‘sensible thing’ in case they did have cancer.
One possibility, as has been found in studies of fear
in cancer screening uptake, is that the quality of the
emotional response is more important than quantity of
emotion [17]. In Vrinten et al.’s (2015) study, quality of
fear was assessed in terms of which speciﬁc fear item
Emotional response to ‘alarm’ symptoms
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was endorsed. One item speciﬁcally mentioned frequent
worry, and that was associated with a higher chance of
screening attendance. Another item mentioned feeling
uncomfortable thinking about cancer, and that was associ-
ated with lower attendance; the worry item was interpreted
as more ‘cognitive’ and the ‘uncomfortable’ item as more
visceral. The present study results ﬁt somewhat with this
model and may also help explain previous mixed ﬁndings
in relation to the role of emotions in time to presentation
[8]. Worry – even frequent worry – motivated help-
seeking partly as a means of alleviating it. Fear, in con-
trast, appeared to be associated with participants feeling
uncomfortable thinking or talking about cancer, which
mostly they regarded as an almost untreatable condition.
The Extended Parallel Process Model [18] is another po-
tential framework. Participants who felt competent to deal
with the threat (i.e. by contacting a doctor) were using a
‘danger control’ approach to manage or reduce the risk.
In this group, it would be predicted that even if worry were
higher, it would probably motivate even more rapid help-
seeking. In contrast, those who felt that the threat could
not be controlled (e.g. cancer was seen as incurable)
adopted ‘fear control’ behaviours, preferring not to discuss
the issue directly or to confront further evidence of the dis-
ease by interacting with doctors. In this group higher fear
would be predicted only to make help-seeking less likely.
Some aspects of the emotional response to symptoms,
which we termed fear (e.g. fear of the incurability of
cancer), overlap with the concept of cancer ‘fatalism’.
Broadly speaking, fatalism denotes the expectation that
death cannot be avoided or postponed when cancer is
diagnosed [19]. Fatalistic beliefs such as ‘people die when
it is their time to die and nothing can change that’ were re-
cently found to be associated with higher risk of advanced
stage at diagnosis of lung and colorectal cancer; strongly
implicating delay in presentation [20]. This ﬁnding em-
phasises the importance of understanding the subtleties
of emotional reactions to the possibility of a cancer diag-
nosis to achieve the goal of diagnosing cancer earlier.
This is the ﬁrst community study to involve an in-depth
exploration of emotional responses to symptoms suggestive
of cancer. Although a minority of people reported an emo-
tional response in relation to their symptoms, this response
could have a signiﬁcant impact on help-seeking. A particu-
lar strength is that we interviewed people who were still
experiencing their ‘alarm’ symptoms, which meant we
avoided discussing ﬂeeting or self-correcting symptoms
and that the symptom experience was a ‘real-time’ event.
A limitation of the study was that, inevitably, we only cap-
tured emotional responses of those willing to share their
symptom experiences. The response rate for the original
survey was higher than found in some previous symptom
research (42%) [21,22], and of that group, 60% agreed to
the interview study; nonetheless, a signiﬁcant proportion
of the target population were not represented. Because some
people ﬁnd it difﬁcult to describe fearful responses, and fear
is also often related to avoidant responses (e.g. avoiding
cancer-related information) [23], those who were most
frightened may have been the least likely to take part in
the research. However, the recruitment method may have
offset this to some extent, because both the survey and inter-
view were conducted without mentioning the word ‘can-
cer’. It has also recently been reported that women and
people from lower SES or non-white ethnic backgrounds
are disproportionally affected by cancer fear [24], so we
may have missed out on that group disproportionately. Fu-
ture work could explore how emotional responses vary by
socio-demographic groups. Another avenue for future work
is to explore how emotional responses might vary according
to symptom type. One possibility would be to focus on spe-
ciﬁc cancers where it is well-established that late presenta-
tion is an issue (e.g. breast cancer) [25]. It might also be
useful in future studies to ask people what could be done
to help reduce their fear.
In conclusion, in this community sample of men and
women over 50 years old, we found two distinct levels of
emotional response to experiencing ongoing cancer ‘alarm’
symptoms, with some individuals describingwhat we called
‘worry’, which was typically low level at the point of inter-
view, while others described ‘fear’ although were often re-
luctant to elaborate. Those who were worried described
what seemed like ‘sensible’ actions to control risk, seeking
medical advice either with the expectation of reassurance
or to avoid a late diagnosis. Those we described as
experiencing fear alluded to the likely failure and unpleasant
features of treatment, and ultimately death. Strikingly, this
group attempted to avoid the cancer discourse altogether
and often required direct questions. These ﬁndings support
ongoing public health initiatives that open the cancer dis-
course and promote cancer awareness. It may also be useful
to incorporate positive messages about advances in treat-
ment toxicity and outcomes to address the negative conse-
quences of fearful responses.
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